Key result
Transfer of beta1AR-specific autoantibodies elicited fulminant dilated cardiomyopathy in mice by agonistically inducing cardiomyocyte apoptosis, which was prevented by caspase inhibition.
Why the study?
Do beta1AR-specific autoantibodies mediate dilated cardiomyopathy by inducing cardiomyocyte apoptosis in a murine model?
Population
SWXJ mice and naive male hosts (murine model of dilated cardiomyopathy)
Design
Preclinical
Authors
Loading...
Beta1AR autoantibodies may drive DCM progression; human studies needed to confirm mechanism and therapeutic potential.
Do beta1AR-specific autoantibodies mediate dilated cardiomyopathy by inducing cardiomyocyte apoptosis in a murine model?
Beta1-adrenergic receptor autoantibodies cause dilated cardiomyopathy by acting as agonists to induce cardiomyocyte apoptosis, providing a mechanistic basis for their pathogenic role.
Jane‐wit et al. (2007) studied Dilated cardiomyopathy. beta1AR-specific autoantibodies was evaluated on Development of fulminant DCM and cardiomyocyte apoptosis. Transfer of beta1AR-specific autoantibodies elicited fulminant dilated cardiomyopathy in mice by agonistically inducing cardiomyocyte apoptosis, which was prevented by caspase inhibition.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: